These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32808374)

  • 1. 8-Oxoguanine DNA glycosylase modulates the cell transformation process in pulmonary fibrosis by inhibiting Smad2/3 and interacting with Smad7.
    Wang Y; Chen T; Pan Z; Lin Z; Yang L; Zou B; Yao W; Feng D; Huangfu C; Lin C; Wu G; Ling H; Liu G
    FASEB J; 2020 Oct; 34(10):13461-13473. PubMed ID: 32808374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RS4651 suppresses lung fibroblast activation via the TGF-β1/SMAD signalling pathway.
    Li S; Xu A; Li Y; Tan C; La Regina G; Silvestri R; Wang H; Qi W
    Eur J Pharmacol; 2021 Jul; 903():174135. PubMed ID: 33940030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
    Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
    Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
    Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
    J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis.
    Liu G; Wang Y; Yang L; Zou B; Gao S; Song Z; Lin Z
    J Cell Mol Med; 2019 May; 23(5):3583-3596. PubMed ID: 30869194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
    Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
    Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TH5487, a small molecule inhibitor of OGG1, attenuates pulmonary fibrosis by NEDD4L-mediated OGG1 degradation.
    Ling H; Song C; Fang Y; Yin Y; Wu Z; Wang Y; Xu Z; Gao S; Li A; Liu G
    Chem Biol Interact; 2022 Aug; 362():109999. PubMed ID: 35654123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
    Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total extract of Xin Jia Xuan Bai Cheng Qi decoction inhibits pulmonary fibrosis via the TGF-β/Smad signaling pathways in vivo and in vitro.
    Qin H; Wen HT; Gu KJ; Hu XD; Yang T; Yan XF; Ye TJ; Huo JL; Hu J
    Drug Des Devel Ther; 2019; 13():2873-2886. PubMed ID: 31695321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.
    Jia L; Sun P; Gao H; Shen J; Gao Y; Meng C; Fu S; Yao H; Zhang G
    J Pharm Pharmacol; 2019 Jun; 71(6):1017-1028. PubMed ID: 30847938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of TGF-β1 and Smad7 gene transfer on the phenotypic changes of rat alveolar epithelial cells.
    Xu GP; Li QQ; Cao XX; Chen Q; Zhao ZH; Diao ZQ; Xu ZD
    Cell Mol Biol Lett; 2007 Sep; 12(3):457-72. PubMed ID: 17457524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
    Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by preventing mitochondrial DNA damage.
    Bindu S; Pillai VB; Kanwal A; Samant S; Mutlu GM; Verdin E; Dulin N; Gupta MP
    Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L68-L78. PubMed ID: 27815257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of enalapril on the expression of TGF-beta1, p-Smad2/3 and Smad7 in renal interstitial fibrosis in rats].
    Ning W; Tao L; Liu C; Sun J; Xiao Y; Hu J; Chen J; Zheng X; Wang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 34(1):27-34. PubMed ID: 19197123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asbestos-induced pulmonary fibrosis is augmented in 8-oxoguanine DNA glycosylase knockout mice.
    Cheresh P; Morales-Nebreda L; Kim SJ; Yeldandi A; Williams DB; Cheng Y; Mutlu GM; Budinger GR; Ridge K; Schumacker PT; Bohr VA; Kamp DW
    Am J Respir Cell Mol Biol; 2015 Jan; 52(1):25-36. PubMed ID: 24918270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalance of receptor-regulated and inhibitory Smads in lung fibroblasts from bleomycin-exposed rats.
    Gonzalez AV; Le Bellego F; Ludwig MS
    Am J Respir Cell Mol Biol; 2007 Feb; 36(2):206-12. PubMed ID: 16931807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamic expression of TGF-beta1/Smad protein in CCl4-induced liver fibrosis and its significance in rats].
    Bao JF; Shi JP; Xu S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):334-7. PubMed ID: 22338217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
    Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K
    Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
    Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
    Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.